In the post pandemic era, as the global economy gradually recovers, Tailin Biotech is targeting the demand gap for pharmaceutical equipment in the international market and accelerating its overseas layout.2022In the face of complex external environments such as geopolitical conflicts and trade protectionism, the company's overseas business continued to grow against the trend, becoming a growth factor for the enterprise“stabilizer”In terms of policies,“The Belt and Road Initiative”InitiativeRCEPThe tariff preferences and the convenience of RMB cross-border payments have provided strong support for Tailin Biotechnology to achieve its globalization strategy.

Open day 2024

Since its establishment, Tailin Biotechnology has been committed toOur mission is to serve human health, focusing on the localization research and development of sterile inspection isolators.2002In the year, the company successfully developed the first sterile inspection isolator, usingVH₂OThe sterilization system and modular structure not only quickly occupied the domestic market, but also successfully entered the international market. From technological dormancy to leveraging opportunities to expand overseas, the continuous convergence of minimally invasive innovations has become the core driving force for overseas expansion.

Tailin Biological First Generation IsolationDeparture device2002

A pharmaceutical factory in EuropeSAT 2024

2015During the Ahma exhibition in Germany, the company's management team conducted in-depth analysis of global market trends, while the R&D team benchmarked against the European UnionGMPThe United StatesFDAWe have developed a glove integrity tester that meets international standards in core technology, verification documents, and software functions. This product accurately adapts to the differentiated needs of different regions around the world and has become a popular overseas star product, helping customers cope with sterile production challenges.

Germany ACHEMA 2015

The company insists onTechnical exchange+Expanding the international market through the dual path of exhibition marketing, by participating in GermanyACHEMAThe United StatesINTERPHEXWaiting for international exhibitions to continuously enhance brand influence. At present, the product has been exported to Southeast Asia, Africa, Europe, etc40More than countries and regions, serving overseas200Our cooperative units not only achieve the scale of "Made in China" going global, but also promote the integration of Chinese pharmaceutical equipment standards with international standards through compliant integrated solutions. In the global industrial chain restructuring, Tailin Biotechnology is becoming a Chinese intelligent manufacturing enterprise participating in international competition with its technological hard power.

Globalization layout is an inevitable choice for the depth of enterprise strategy. In the international map of Tailin Biotechnology, with innovative equipment such as bacterial culture chambers, sterile inspection isolators, and total organic carbon analyzers, we have first broken through the Asian market. as early as2012In the year, the microbiological testing and control series products achieved breakthrough in the Japanese market;2014In the year, large-scale pharmaceutical equipment sterile inspection isolators were successfully delivered in Vietnam. After years of deep cultivation, Tailin Biotechnology has achieved a significant increase in brand influence in the Asia Pacific market.

The first dissolution instrument exported overseas

The European and American medical device markets gather top technologies and products from around the world, with extremely strict admission standards.2024In the year, Tailin Biotech made a strong breakthrough, with a strategic focus on markets such as Europe and North America. Our filter membrane production line is located in GermanyFILTECHThe exhibition has achieved great success, and the orders for glove integrity testers in the United States have also seen rapid growth.

Germany Filtech 2024

In recent years, with the deepening of overseas strategies, the annual sales growth rate of international business has exceeded40%The foundation of the South Asian and Asia Pacific markets is becoming increasingly solid, with sustained and steady growth; Strong breakthroughs have been made in North America and emerging markets, demonstrating enormous potential; The business in the Middle East and Africa regions is showing a high-speed growth trend. On this basis, a collaborative and efficient global marketing and service network has accelerated its formation, comprehensively enhancing the company's international competitiveness.

Overseas market layout map

Based on more than ten years of technological research and development accumulation, Tailin Biotechnology is deeply promoting its localization strategy. The company has established local distribution and service systems in South Korea, Thailand, India, Bangladesh, Türkiye, Russia, Ukraine, Mexico, Argentina, the United Arab Emirates and other countries and regions to provide customers with customized solutions, quick response after-sales and continuous technical support. Simultaneously withGSKTheAurobindoTheDr. Reddy'sBy establishing cooperative relationships with global multinational pharmaceutical companies and research institutions, we can further enhance the foundation of global trust.

Seminar on Environmental Microbial Monitoring Analysis and Biological Indicator Selection in Taiwan, China, China 2025

Türkiye dealer seminar 2025

The company innovatively adopts'Standard equipment+consumables'Our integrated solution covers the entire process of installation and debugging, technical training, after-sales support, and other services to meet user needs. This highly integrated and intelligent solution demonstrates significant advantages in overseas projects with complex environments, supply chain fluctuations, and high efficiency requirements.

When technology autonomy is deeply combined with localization, Chinese enterprises can build in the tide of anti globalizationThe paradigm of both globalization and localization. In the future, Tailin Biotechnology will increase its investment in overseas resources, establish localized operation centers covering research and development, marketing, and after-sales, enhance its localized service capabilities, and achieve a transformation and upgrading from a single "product output" to "ecological co construction".

The overseas expansion path of Tailin Biotechnology is a microcosm of the rise of Chinese intelligent manufacturing on the global stage. Through technological innovation, deep market cultivation, and service upgrading, Tailin Biotechnology is restructuring its international supply chain discourse with a resilient growth attitude, achieving a transformation fromThe strategic upgrade from 'going global' to 'weaving networks'.